Shareholders of these three health-care stocks could be wishing for a do-over for the start of July.
One of the week's big losers appears to have been hurt by being dropped from a well-known index. Another reported late-stage clinical study results that caused some to worry. And the third was stung by the posting of a warning letter by the U.S. Food and Drug Administration.
Which three health-care stocks were crushed by the market this week? Find out by watching the slideshow below.
This coming blockbuster could help you crush the market
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.